Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract Health Condition 2: null- patients suffering from Leucorrhea
Conditions
Interventions
Intervention1: Tab Lucronil
: Ashwagandha Extract (Withania somnifera 40 mg
Vidari Extract (Pueraria tuberosa)20 mg
Badi Elaichi Extract (Amomum subulatum)30 mg
Ashok Chhal Extract (Saraca
indica) 4
Sponsors
yurvedic Research Foundation Pvt ltd
Eligibility
Inclusion criteria
Inclusion criteria: Married females of Age group 20 to 40 years having leucorrhoea due to non-infective cervical lesions e.g. cervical erosion, chronic cervicitis, mucous polyps, increased pelvic congestion e.g. uterine prolapsed, acquired retroverted uterus, chronic pelvic inflammation Controlled diabetes
Exclusion criteria
Exclusion criteria: i. Pregnant or lactating women ii. Patients on Oral Contraceptive Pills iii. Patients with IUCD iv. Patients with physiological leucorrhoea (e.g. during ovulation, pre-menstrual, pregnancy) v. Patients with abnormal (excessive) vaginal discharge due to neoplasmic changes vi. Positive history of venereal diseases vii. Patients suffering from uncontrolled diabetes viii. Patients with Anemia (Hb% below 7)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcomes of the study will be measured in terms of clinical signs - per vaginal examination and symptoms Pap smear test microbiological improvement. Timepoint: Every 15 days for a period of one month | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the safety and tolerability of the formulation in patientsa suffering from LeucorrheaTimepoint: Every 15 days | — |
Countries
India
Contacts
Public ContactDr Supriya Bhalerao
Interactive Research School for Health Affairs
Outcome results
None listed